Figure S4. The prediction of CarHE on ccrcc patient 2. A. The H&E image of the FFPF tumor. B. Immune cell abundance predicted by CarHE and ground truth. C. Average expression of the non-switched IGHM gene, the switched immunoglobulin genes IGHG1 and IGHA1, and the fibroblast marker COL1A1.